Commodore Capital as of March 31, 2025
Portfolio Holdings for Commodore Capital
Commodore Capital holds 31 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 13.9 | $188M | 4.5M | 42.09 | |
| Nuvalent Inc-a (NUVL) | 9.7 | $132M | 1.9M | 70.92 | |
| Enliven Therapeutics (ELVN) | 6.8 | $92M | 4.7M | 19.68 | |
| Soleno Therapeutics (SLNO) | 6.1 | $82M | 1.2M | 71.45 | |
| Xenon Pharmaceuticals (XENE) | 5.7 | $78M | 2.3M | 33.55 | |
| Alkermes SHS (ALKS) | 4.7 | $64M | 2.0M | 33.02 | |
| Agios Pharmaceuticals (AGIO) | 4.7 | $64M | 2.2M | 29.30 | |
| Vaxcyte (PCVX) | 4.6 | $62M | 1.7M | 37.76 | |
| Vera Therapeutics Cl A (VERA) | 4.5 | $62M | 2.6M | 24.02 | |
| Celldex Therapeutics Com New (CLDX) | 4.3 | $58M | 3.2M | 18.15 | |
| Scholar Rock Hldg Corp (SRRK) | 4.1 | $56M | 1.7M | 32.15 | |
| Cogent Biosciences (COGT) | 3.9 | $53M | 8.9M | 5.99 | |
| Miragen Therapeutics (VRDN) | 3.6 | $49M | 3.6M | 13.48 | |
| Nurix Therapeutics (NRIX) | 3.5 | $47M | 4.0M | 11.88 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.5 | $34M | 2.4M | 14.38 | |
| Spyre Therapeutics Com New (SYRE) | 2.4 | $32M | 2.0M | 16.14 | |
| Pharvaris N V (PHVS) | 2.2 | $30M | 1.9M | 15.70 | |
| Mind Medicine Mindmed Com New (MNMD) | 2.0 | $27M | 4.5M | 5.85 | |
| Solid Biosciences Com New (SLDB) | 1.6 | $22M | 5.8M | 3.70 | |
| Bright Minds Biosciences Com New (DRUG) | 1.3 | $18M | 500k | 36.07 | |
| Cardiff Oncology (CRDF) | 1.2 | $17M | 5.4M | 3.14 | |
| Oruka Therapeutics (ORKA) | 1.1 | $15M | 1.4M | 10.26 | |
| Inhibikase Therapeutics Com New (IKT) | 0.9 | $12M | 5.3M | 2.19 | |
| Oric Pharmaceuticals (ORIC) | 0.8 | $11M | 2.0M | 5.58 | |
| Apogee Therapeutics (APGE) | 0.8 | $11M | 290k | 37.36 | |
| Neurogene (NGNE) | 0.8 | $11M | 925k | 11.71 | |
| Tyra Biosciences (TYRA) | 0.7 | $8.8M | 950k | 9.30 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.6 | $7.7M | 750k | 10.30 | |
| Celcuity (CELC) | 0.5 | $7.0M | 696k | 10.11 | |
| Vistagen Therapeutics Ord (VTGN) | 0.3 | $3.9M | 1.6M | 2.50 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $3.9M | 483k | 8.01 |
